![Lars Guldbæk Karlsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Lars Guldbæk Karlsson first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lars Guldbæk Karlsson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Cristal Delivery BV
![]() Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chairman | |
FEEDBACK PLC | Packaged Software | Chairman Director/Board Member | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member | |
University of Sussex | College/University | Undergraduate Degree | |
Boehringer Ingelheim BV
![]() Boehringer Ingelheim BV Drugstore ChainsRetail Trade An international, innovative, pharmaceutical, family business Boehringer Ingelheim BV is an international, innovative pharmaceutical company that focuses on the development and marketing of new drugs that help improve the health and welfare of humans and animals. The company was established in 1945 and is headquartered in Alkmaar, the Netherlands. | Drugstore Chains | Corporate Officer/Principal | |
Astra Pharmaceuticals Ltd.
![]() Astra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Astra Pharmaceuticals Ltd. manufactures & wholesales pharmaceutical products. The company was established in 1908 and is headquartered in London, GB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lonza Biologics Plc
![]() Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Dr. Reddy's Research & Development BV
![]() Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
SMALL PHARMA INC. | Drugstore Chains | Chief Operating Officer | |
VERNALIS | Pharmaceuticals: Major | Chief Executive Officer | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
ENTERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Birmingham School | College/University | Graduate Degree | |
University of Aston | College/University | Doctorate Degree | |
NUFORMIX PLC | Biotechnology | Chairman | |
Procure Therapeutics Ltd. | Chairman | ||
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Skyline Vet Pharma, Inc.
![]() Skyline Vet Pharma, Inc. Pharmaceuticals: MajorHealth Technology Skyline Vet Pharma, Inc. engages in the manufacture of veterinary pharmaceutical products. The company was founded by Serge R. Martinod and George F. Murphy and is headquartered in Groton, CT. | Pharmaceuticals: Major | Director/Board Member | |
Karlsruher Institut für Technologie | College/University | Doctorate Degree | |
Renaissance Co., Inc. | Founder | ||
Strathclyde Business School | College/University | Corporate Officer/Principal | |
Pension Trustees Ltd. | Director/Board Member | ||
PA Consulting Group Ltd.
![]() PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Ernst & Young LLP (United Kingdom)
![]() Ernst & Young LLP (United Kingdom) Packaged SoftwareTechnology Services Ernst & Young LLP engages in the provision of accounting services. The company was founded on April 6, 2001 and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member | |
The University of Edinburgh | College/University | Undergraduate Degree | |
Berlin Cures Holding AG
![]() Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Biotechnology | Chief Executive Officer | |
MEDIGENE AG | Biotechnology | Corporate Officer/Principal | |
Kymab Group Ltd.
![]() Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Chief Executive Officer | |
FLERIE INVEST AB | Pharmaceuticals: Major | Founder | |
Merck Healthcare | Chief Operating Officer | ||
Weizmann UK
![]() Weizmann UK Miscellaneous Commercial ServicesCommercial Services Weizmann UK is a non-profit company that operates scientific research institutes. The company is based in London, UK. The British company was founded in 1950. | Miscellaneous Commercial Services | Director/Board Member | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Mediar Therapeutics, Inc.
![]() Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Moonlake Immunotherapeutics AG
![]() Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Chairman | |
Nemesis Biosciences Ltd.
![]() Nemesis Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Nemesis Biosciences Ltd. develops and commercializes therapeutic agents that resurrect the antibiotic sensitivity of currently resistant microbial pathogens. Its symbiotics kill pathogenic microorganisms directly and/or make them susceptible to currently existing antibiotics. The company was founded by Frank Massam, Conrad Lichtenstein and Gi Mikawa in March 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
South West Peninsula AHSN Ltd.
![]() South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | Medical/Nursing Services | Chairman | |
Cabrellis Pharmaceuticals Corp.
![]() Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Tioga Pharmaceuticals, Inc.
![]() Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Forward Ventures Services LLC
![]() Forward Ventures Services LLC Investment ManagersFinance Forward Ventures Services LLC (Forward Ventures ) is a venture capital firm founded in 1990 by Standish M. Fleming and Ivor Royston. The firm is headquartered in San Diego, California. | Investment Managers | Private Equity Investor | |
NovaCardia, Inc.
![]() NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
GeneOhm Sciences, Inc.
![]() GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Medical Specialties | Chairman |
Statistics
International
United Kingdom | 24 |
United States | 16 |
Germany | 5 |
Netherlands | 4 |
Switzerland | 4 |
Sectoral
Health Technology | 30 |
Consumer Services | 8 |
Retail Trade | 4 |
Commercial Services | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 35 |
Chairman | 22 |
Chief Executive Officer | 15 |
Independent Dir/Board Member | 10 |
Corporate Officer/Principal | 7 |
Most connected contacts
Insiders | |
---|---|
Stuart J. M. Collinson | 25 |
Alastair Riddell | 24 |
Simon Sturge | 20 |
Alistair Gray | 8 |
Oliver von Stein | 5 |
- Stock Market
- Insiders
- Lars Guldbæk Karlsson
- Company connections